Belen Navarro

Majadahonda, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.

Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.

Journal: HemaSphere

Published: December 11, 2025

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Journal: Blood advances

Published: November 25, 2024

18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.

18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.

Journal: Expert review of hematology

Published: February 01, 2024

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

Journal: Cancers

Published: January 21, 2024

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: November 23, 2023

New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.

New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.

Journal: HemaSphere

Published: September 16, 2023

Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.

Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.

Journal: British journal of haematology

Published: March 07, 2023

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.

Journal: British journal of haematology

Published: January 09, 2023

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.

Journal: Cancers

Published: March 12, 2021

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.

Journal: HemaSphere

Published: November 15, 2020

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.

Journal: British journal of haematology

Published: February 19, 2020

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.

Journal: European journal of haematology

Published: October 17, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026